Delisted
This security is no longer actively traded. Historical data is preserved for reference.No holders in 2026-Q2, no recent price data
DAY ONE BIOPHARMACEUTICALS I
DAWN·23954D109·US·Common Stock·Healthcare - Biotechnology-Activist
DAWN (DAY ONE BIOPHARMACEUTICALS I) is held by 118 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($151M), FIL Ltd ($88.6M), VANGUARD CAPITAL MANAGEMENT LLC ($72M).
118
Holders
(9 Elite)
$1.2B
Total Value
56%
Consensus
13F: Insider & Congress:
No verdict yet — fewer than 2 funds hold DAWN.
Top Holders
Showing 1-20 of 141
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer